Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Israeli Equity Fund Approaches Annual Peak on Strong Momentum

Felix Baarz by Felix Baarz
January 17, 2026
in Analysis, Emerging Markets, ETF, Market Commentary
0
iShares MSCI Israel ETF Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

The iShares MSCI Israel ETF (EIS) is trading near its 52-week high following a substantial rally, fueled by robust domestic equity performance, significant investor inflows, and major technology sector transactions over the past year. The fund’s trajectory raises questions about the sustainability of its current momentum.

Performance and Key Metrics

Recent performance figures underscore the fund’s strength. Over a one-year period, it has delivered gains estimated between 48% and 55%, with a year-to-date increase of 5.7%. As of the latest data, the fund manages approximately $717.6 million in assets and carries an expense ratio of 0.59%.

Liquidity remains consistent, with a 30-day average volume near 93,800 shares and a recent daily volume around 100,200 shares. The fund has also seen substantial net inflows, attracting roughly $308 million over the last twelve months. Its market price has traded at a narrow premium to its net asset value, typically between +0.3% and +0.45%, indicating efficient market pricing.

Portfolio Composition and Sector Exposure

This ETF offers physical exposure to the MSCI Israel Capped Investable Market Index, holding between 110 and 120 individual securities. A notable feature is its high concentration: the top ten holdings account for about 52% of the total portfolio. Major positions include Teva Pharmaceutical, Bank Leumi, Bank Hapoalim, CyberArk, and Elbit Systems. This concentration means the performance of a few key companies can significantly impact the overall fund.

Should investors sell immediately? Or is it worth buying iShares MSCI Israel ETF?

From a sector perspective, financials represent the largest allocation at approximately 32%. Technology is the second-largest sector, comprising nearly 25% of the fund, followed by industrial, healthcare, and real estate companies. This provides a broader exposure to the Israeli economy compared to more narrowly focused technology competitors.

Drivers and Forward-Looking Considerations

Several structural factors could support continued interest. The Tel Aviv Stock Exchange’s shift to a Monday-Friday trading week is expected to improve market accessibility for international investors. Furthermore, significant deals and investments by global corporations into Israel’s cybersecurity and artificial intelligence firms highlight the enduring appeal of its tech sector. The Bank of Israel projects robust GDP growth of around 5.2% for 2026, which may bolster corporate earnings prospects.

However, the strong gains witnessed in 2025 have elevated valuations. The fund’s near-term path is likely tied to the performance of its dominant sectors. A sustained rally in the TA-125 index would likely benefit EIS, while pronounced weakness in technology or financial stocks could place the ETF under considerable pressure. Key indicators to monitor in the coming weeks include the trajectory of the TA-125, continued fund flow data, and fundamental news from the ETF’s largest holdings.

Ad

iShares MSCI Israel ETF Stock: Buy or Sell?! New iShares MSCI Israel ETF Analysis from February 7 delivers the answer:

The latest iShares MSCI Israel ETF figures speak for themselves: Urgent action needed for iShares MSCI Israel ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

iShares MSCI Israel ETF: Buy or sell? Read more here...

Tags: iShares MSCI Israel ETF
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

February 7, 2026
Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Next Post
JD.com Stock

Diverging Views Shape the Investment Outlook for JD.com

ADP Stock

ADP's Robust Quarterly Performance and Enhanced Shareholder Returns

Nvidia Stock

Nvidia's AI Ambitions Gain Concrete Validation

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com